Methylergonovine-induced hypertonus in term pregnancy. A case report.
The administration of methylergonovine maleate to a patient at term is rare. A patient received the drug at 36 weeks' gestation, with subsequent development of fetal distress secondary to uterine tetany. Treatment with terbutaline and magnesium sulfate was unsuccessful in alleviating the uterine hypertonus, necessitating cesarean section.
Moise
K J
KJ
Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030.
Carpenter
R J
RJ
D000293:Adolescent; D002585:Cesarean Section; D005260:Female; D005316:Fetal Distress / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D008278:Magnesium Sulfate / Q000627:therapeutic use; D008297:Male; D008755:Methylergonovine / Q000009:adverse effects*; D009122:Muscle Hypertonia / Q000139:chemically induced / Q000188:drug therapy; D011247:Pregnancy; D013726:Terbutaline / Q000627:therapeutic use; D014590:Uterine Contraction / Q000187:drug effects
D008278:Magnesium Sulfate; D013726:Terbutaline; D008755:Methylergonovine